Oxxon Therapeutics, a UK therapeutic vaccine company, has been acquired by Oxford BioMedica in a deal that values the business at £16m. It was backed by ISIS Capital, MVM Life Science Partners, NIF Ventures, NeoMed and Quester.
Oxxon Therapeutics, a UK therapeutic vaccine company, has been acquired by Oxford BioMedica in a deal that values the business at £16m. It was backed by ISIS Capital, MVM Life Science Partners, NIF Ventures, NeoMed and Quester.
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: